{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:35:34Z","timestamp":1781850934230,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00296-018-3991-7","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T06:33:27Z","timestamp":1517985207000},"page":"1293-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-112X","authenticated-orcid":false,"given":"Juan","family":"Gonz\u00e1lez-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Raya-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-0843","authenticated-orcid":false,"given":"Ines","family":"Losada-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Cacheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5147-5987","authenticated-orcid":false,"given":"Bartomeu","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"3991_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"121","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R et al (2016) Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med 121:91\u201399","journal-title":"Respir Med"},{"key":"3991_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheumatol 52:1571\u20131576","journal-title":"Arthritis Rheumatol"},{"key":"3991_CR3","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2169\/internalmedicine.53.2769","volume":"53","author":"K Tamai","year":"2014","unstructured":"Tamai K, Tachikawa R, Otsuka K, Ueda H, Hosono Y, Tomii K (2014) Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms. Intern Med 53:2515\u20132519","journal-title":"Intern Med"},{"key":"3991_CR4","first-page":"1","volume":"10","author":"V Ortiz-Santamaria","year":"2017","unstructured":"Ortiz-Santamaria V, Babot A, Ferrer C (2017) Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation. Scand J Rheumatol 10:1\u20133","journal-title":"Scand J Rheumatol"},{"key":"3991_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646\u2013664","journal-title":"Am J Respir Crit Care Med"},{"key":"3991_CR6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T et al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1713\u20131719","journal-title":"Rheumatology"},{"key":"3991_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1378\/chest.10-0194","volume":"138","author":"A Fischer","year":"2010","unstructured":"Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 138:251\u2013256","journal-title":"Chest"},{"key":"3991_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, ERS\/ATS Task Force on Undifferentiated Forms of CTD-ILD et al (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976\u2013987","journal-title":"Eur Respir J"},{"key":"3991_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","volume":"91","author":"NF Chaisson","year":"2012","unstructured":"Chaisson NF, Paik J, Orbai AM, Casciola-Rosen L, Fiorentino D, Danoff S, Rosen A (2012) A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature. Medicine (Baltimore) 91:220\u2013228","journal-title":"Medicine (Baltimore)"},{"key":"3991_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/acr.21985","volume":"65","author":"Z Chen","year":"2013","unstructured":"Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, Sun L (2013) Utility of anti-melanoma differentiation associated gene 5 antibody measurement in identifying patients with dermatomyositis and high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken) 65:1316\u20131324","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3991_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3899\/jrheum.160682","volume":"44","author":"S Moghadam-Kia","year":"2017","unstructured":"Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R (2017) Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis. J Rheumatol 44:319\u2013325","journal-title":"J Rheumatol"},{"key":"3991_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.21037\/atm.2017.03.94","volume":"5","author":"RD Sontheimer","year":"2017","unstructured":"Sontheimer RD (2017) MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis. Ann Transl Med 5:160","journal-title":"Ann Transl Med"},{"key":"3991_CR13","doi-asserted-by":"crossref","first-page":"26552","DOI":"10.18632\/oncotarget.15716","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Wang Q, Yang F et al (2017) Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget 8:26552\u201326564","journal-title":"Oncotarget"},{"key":"3991_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","volume":"51","author":"Y Muro","year":"2012","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M (2012) Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission. Rheumatology 51:800\u2013804","journal-title":"Rheumatology"},{"key":"3991_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23:496\u2013502","journal-title":"Mod Rheumatol"},{"key":"3991_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M et al (2017) Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176:395\u2013402","journal-title":"Br J Dermatol"},{"key":"3991_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23:496\u2013502","journal-title":"Mod Rheumatol"},{"key":"3991_CR18","first-page":"1","volume":"11","author":"Y Fujiki","year":"2017","unstructured":"Fujiki Y, Kotani T, Isoda K et al (2017) Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Mod Rheumatol 11:1\u20138","journal-title":"Mod Rheumatol"},{"key":"3991_CR19","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2169\/internalmedicine.55.5774","volume":"55","author":"H Chino","year":"2016","unstructured":"Chino H, Sekine A, Baba T, qt al (2016) Radiological and pathological correlation in anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage. Intern Med 55:2241\u20132246","journal-title":"Intern Med"},{"key":"3991_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0032-1325158","volume":"33","author":"S Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay S, Parambil JG (2012) Acute interstitial pneumonia (AIP): relationship to Hamman\u2013Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS). Semin Respir Crit Care Med 33:476\u2013485","journal-title":"Semin Respir Crit Care Med"},{"key":"3991_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/0961203316651748","volume":"25","author":"R Nakashima","year":"2016","unstructured":"Nakashima R, Hosono Y, Mimori T (2016) Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25:925\u2013933","journal-title":"Lupus"},{"key":"3991_CR22","first-page":"1","volume":"25","author":"S Hoa","year":"2017","unstructured":"Hoa S, Troyanov Y, Fritzler MJ et al (2017) Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review. Scand J Rheumatol 25:1\u201315","journal-title":"Scand J Rheumatol"},{"key":"3991_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jbspin.2014.01.005","volume":"81","author":"R Goussot","year":"2014","unstructured":"Goussot R, Theulin A, Goetz J, Sibilia J, Gottenberg JE, Meyer A (2014) An arthro-dermato-pulmonary syndrome associated with anti-MDA5 antibodies. Jt Bone Spine 81:266","journal-title":"Jt Bone Spine"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-018-3991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:59:50Z","timestamp":1744174790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-018-3991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3991"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-3991-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent was obtained from the patient described in the case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}